State Street’s Chembio diagnostics, Inc. CEMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-53,409
Closed -$23.6K 4846
2023
Q1
$23.6K Hold
53,409
﹤0.01% 4662
2022
Q4
$11.7K Hold
53,409
﹤0.01% 4792
2022
Q3
$19K Hold
53,409
﹤0.01% 4840
2022
Q2
$35K Buy
53,409
+2,500
+5% +$1.66K ﹤0.01% 4800
2022
Q1
$42K Hold
50,909
﹤0.01% 4827
2021
Q4
$58K Hold
50,909
﹤0.01% 4675
2021
Q3
$127K Sell
50,909
-41,200
-45% -$114K ﹤0.01% 4486
2021
Q2
$274K Sell
92,109
-193,771
-68% -$675K ﹤0.01% 4095
2021
Q1
$1M Buy
285,880
+33,500
+13% +$187K ﹤0.01% 3627
2020
Q4
$1.2M Sell
252,380
-1,726
-0.7% -$8.91K ﹤0.01% 3528
2020
Q3
$1.24M Buy
254,106
+75,556
+42% +$358K ﹤0.01% 3374
2020
Q2
$580K Buy
+178,550
New +$1.7M ﹤0.01% 3519

Other funds holding CEMI

State Street's CEMI Position: Q2 2023 in Review

State Street sold out of Chembio diagnostics, Inc. (CEMI) in Q2 2023, closing a stake of 53,409 shares — an estimated $23.6K sold.

State Street first reported a position in CEMI in Q2 2020 and held it in 12 quarters. The position peaked at $1.24M in Q3 2020. 1 fund tracked by Wall St. Rank holds CEMI as of Q2 2023.

  • State Street reported no remaining Chembio diagnostics, Inc. position as of Q2 2023 after selling out during the quarter.
  • State Street sold 53,409 Chembio diagnostics, Inc. shares in Q2 2023, an estimated $23.6K.
  • State Street first reported a position in Chembio diagnostics, Inc. in Q2 2020 and held it in 12 quarters.
  • State Street's Chembio diagnostics, Inc. position peaked at $1.24M in Q3 2020.
  • 1 fund tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q2 2023.

Based on State Street's 13F filing for Q2 2023, filed 14 Aug 2023.